Submitted by Anonymous (not verified) on 27 September 2023 - 8:36
Human medicines European public assessment report (EPAR): Epclusa, sofosbuvir,velpatasvir, Hepatitis C, Chronic, Date of authorisation: 06/07/2016, Revision: 22, Status: Authorised
Source: